Medizinische Universität Graz Austria/Österreich - Forschungsportal

Publikationen

Suchbegriffe: EARLY BREAST CANCER, . Treffer: 37

2023

Weber, WP; Davide, Gentilini, O; Morrow, M; Montagna, G; de, Boniface, J; Fitzal, F; Wyld, L; Rubio, IT; Matrai, Z; King, TA; Saccilotto, R; Galimberti, V; Maggi, N; Andreozzi, M; Sacchini, V; Castrezana, López, L; Loesch, J; Schwab, FD; Eller, R; Heidinger, M; Haug, M; Kurzeder, C; Di, Micco, R; Banys-Paluchowski, M; Ditsch, N; Harder, Y; Paulinelli, RR; Urban, C; Benson, J; Bjelic-Radisic, V; Potter, S; Knauer, M; Thill, M; Vrancken, Peeters, MJ; Kuemmel, S; Heil, J; Gulluoglu, BM; Tausch, C; Ganz-Blaettler, U; Shaw, J; Dubsky, P; Poortmans, P; Kaidar-Person, O; Kühn, T; Gnant, M Uncertainties and controversies in axillary management of patients with breast cancer.
Cancer Treat Rev. 2023; 117:102556 Doi: 10.1016/j.ctrv.2023.102556
PubMed FullText FullText_MUG

2022

Posch, F; Niedrist, T; Glantschnig, T; Firla, S; Moik, F; Kolesnik, E; Wallner, M; Verheyen, N; Jost, PJ; Zirlik, A; Pichler, M; Balic, M; Rainer, PP Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer.
Front Cardiovasc Med. 2022; 9: 933428 Doi: 10.3389/fcvm.2022.933428 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Singer, CF; Jahn, SW; Rudas, M; Bago-Horvath, Z; Fitzal, F; Abete, L; Moinfar, F; Gnant, M; Filipits, M, , Austrian, Breast, and, Colorectal, Cancer, Study, Group, (ABCSG) Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry.
Breast. 2022; 64:127-133 Doi: 10.1016/j.breast.2022.05.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stöger, H; Greil, R Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT).
Breast Care (Basel). 2022; 17(1): 1-9. Doi: 10.1159/000512467 [OPEN ACCESS]
PubMed FullText FullText_MUG

Zhou, Q; Gampenrieder, SP; Frantal, S; Rinnerthaler, G; Singer, CF; Egle, D; Pfeiler, G; Bartsch, R; Wette, V; Pichler, A; Petru, E; Dubsky, PC; Bago-Horvath, Z; Fesl, C; Rudas, M; Ståhlberg, A; Graf, R; Weber, S; Dandachi, N; Filipits, M; Gnant, M; Balic, M; Heitzer, E Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.
Clin Cancer Res. 2022; 28(4):697-707 Doi: 10.1158/1078-0432.CCR-21-3231 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2021

Balic, M; Rinnerthaler, G; Bartsch, R Position Paper on the Value of Extended Adjuvant Therapy with Neratinib for Early HER2+/HR+ Breast Cancer
BREAST CARE. 2021; Doi: 10.1159/000518696 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Filipits, M; Rudas, M; Singer, CF; Fitzal, F; Bago-Horvath, Z; Greil, R; Balic, M; Lax, SF; Halper, S; Hulla, W; Wu, NC; Liu, X; Weidler, J; Bates, M; Hlauschek, D; Gnant, M; Dubsky, P ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
ESMO Open. 2021; 6(4): 100228 Doi: 10.1016/j.esmoop.2021.100228 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Gampenrieder, SP; Pircher, M; Fesl, C; Rinnerthaler, G; Mlineritsch, B; Greil-Ressler, S; Steger, GG; Sagaster, V; Fitzal, F; Exner, R; Devyatko, Y; Balic, M; Stoger, H; Suppan, C; Bauernhofer, T; Singer, CF; Pfeiler, G; Seifert, M; Helfgott, R; Heck, D; Rumpold, H; Kwasny, W; Wieder, U; Gnant, M; Greil, R Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
BREAST CARE. 2021; Doi: 10.1159/000516157
Web of Science FullText FullText_MUG

Suppan, C; Posch, F; Mueller, HD; Mischitz, N; Steiner, D; Klocker, EV; Setaffy, L; Bargfrieder, U; Hammer, R; Hauser, H; Jost, PJ; Dandachi, N; Lax, S; Balic, M Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity.
Cancers (Basel). 2021; 13(10): Doi: 10.3390/cancers13102492 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Thomssen, C; Balic, M; Harbeck, N; Gnant, M St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer.
BREAST CARE. 2021; 16(2): 135-143. Doi: 10.1159/000516114 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2020

Bago-Horvath, Z; Rudas, M; Singer, CF; Greil, R; Balic, M; Lax, SF; Kwasny, W; Hulla, W; Gnant, M; Filipits, M Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5.
Clin Cancer Res. 2020; 26(21): 5682-5688. Doi: 10.1158/1078-0432.CCR-20-0673
Web of Science PubMed FullText FullText_MUG

Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Fesl, C; Sölkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stöger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.
Eur J Cancer. 2020; 127(4):12-20 Doi: 10.1016/j.ejca.2019.11.024
Web of Science PubMed FullText FullText_MUG

Hurvitz, SA; Martin, M; Press, MF; Chan, D; Fernandez-Abad, M; Petru, E; Rostorfer, R; Guarneri, V; Huang, CS; Barriga, S; Wijayawardana, S; Brahmachary, M; Ebert, PJ; Hossain, A; Liu, J; Abel, A; Aggarwal, A; Jansen, VM; Slamon, DJ Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR⁺/HER2^- Breast Cancer.
CLIN CANCER RES. 2020; 26(3): 566-580. Doi: 10.1158/1078-0432.CCR-19-1425 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Taumberger, N; Pernthaler, B; Schwarz, T; Bjelic-Radisic, V; Pristauz, G; Aigner, RM; Tamussino, K Lymphoscintigraphy for Sentinel Lymph Node Biopsy in Breast Cancer: Do We Need a Delayed Image?
Breast Care (Basel). 2020; 15(1): 55-59. Doi: 10.1159/000496504 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2019

Balic, M; Thomssen, C; Würstlein, R; Gnant, M; Harbeck, N St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment.
Breast Care (Basel). 2019; 14(2):103-110 Doi: 10.1159/000499931 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Deniz, M; DeGregorio, A; DeGregorio, N; Bekes, I; Widschwendter, P; Schochter, F; Ernst, K; Scholz, C; Bauer, EC; Aivazova-Fuchs, V; Weissenbacher, T; Kost, B; Jueckstock, J; Andergassen, U; Steidl, J; Trapp, E; Fasching, PA; Häberle, L; Beckmann, MW; Schneeweiss, A; Schrader, I; Janni, W; Rack, B; Friedl, TW Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study.
Breast. 2019; 44(3):81-89 Doi: 10.1016/j.breast.2018.12.008 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Gnant, M; Pfeiler, G; Steger, GG; Egle, D; Greil, R; Fitzal, F; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Jakesz, R; Marth, C; Sevelda, P; Mlineritsch, B; Exner, R; Fesl, C; Frantal, S; Singer, CF, , Austrian, Breast, and, Colorectal, Cancer, Study, Group Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol. 2019; 20(3):339-351 Doi: 10.1016/S1470-2045(18)30862-3
Web of Science PubMed FullText FullText_MUG

Singer, CF; Filipits, M; Jahn, SW; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Kastner, M; Schmitt, M; Moinfar, F; Gnant, M Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Breast. 2019; 46(14):101-107 Doi: 10.1016/j.breast.2019.05.007 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2018

Alunni-Fabbroni, M; Majunke, L; Trapp, EK; Tzschaschel, M; Mahner, S; Fasching, PA; Fehm, T; Schneeweiss, A; Beck, T; Lorenz, R; Friedl, TWP; Janni, W; Rack, B; SUCCESS Study Group Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
BMC Cancer. 2018; 18(1):141-141 Doi: 10.1186/s12885-018-4020-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Schochter, F; Rack, B; Tzschaschel, M; Polasik, A; Andergassen, U; Trapp, E; Alunni-Fabbroni, M; Schneeweiss, A; Müller, V; Pantel, K; Gade, J; Lorenz, R; Rezai, M; Tesch, H; Soeling, U; Fehm, T; Mahner, S; Schindlbeck, C; Lichtenegger, W; Beckmann, MW; Fasching, PA; Janni, W; Friedl, TWP; SUCCESS Study Group Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
Oncol Res Treat. 2018; 41(3):93-98 Doi: 10.1159/000485566 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2017

Schramm, A; Schochter, F; Friedl, TWP; de Gregorio, N; Andergassen, U; Alunni-Fabbroni, M; Trapp, E; Jaeger, B; Heinrich, G; Camara, O; Decker, T; Ober, A; Mahner, S; Fehm, TN; Pantel, K; Fasching, PA; Schneeweiss, A; Janni, W; Rack, BK; SUCCESS Study Group Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Clin Breast Cancer. 2017; 17(4):279-285 Doi: 10.1016/j.clbc.2016.11.008
Web of Science PubMed FullText FullText_MUG

Singer, CF; Tan, YY; Fitzal, F; Steger, GG; Egle, D; Reiner, A; Rudas, M; Moinfar, F; Gruber, C; Petru, E; Bartsch, R; Tendl, KA; Fuchs, D; Seifert, M; Exner, R; Balic, M; Bago-Horvath, Z; Filipits, M; Gnant, M; Austrian Breast and Colorectal Cancer Study Group Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer.
Clin Cancer Res. 2017; 23(14):3676-3683 Doi: 10.1158/1078-0432.CCR-16-2373 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Suppan, C; Balic, M Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016.
Memo. 2017; 10(2):82-85 Doi: 10.1007/s12254-017-0328-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Luschin, G; Habersack, M Oral information about side effects of endocrine therapy for early breast cancer patients at initial consultation and first follow-up visit: an online survey.
Health Commun. 2014; 29(4):421-426 Doi: 10.1080/10410236.2012.743096
Web of Science PubMed FullText FullText_MUG

Peintinger, F Using molecular profiles to tailor treatment in breast cancer: are they ready for prime time?
Curr Opin Obstet Gynecol. 2014; 26(1):21-26 Doi: 10.1097/GCO.0000000000000041
Web of Science PubMed FullText FullText_MUG

Rugani, P; Luschin, G; Jakse, N; Kirnbauer, B; Lang, U; Acham, S Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer.
Clin Oral Investig. 2014; 18(2):401-407 Doi: 10.1007/s00784-013-1012-5
Web of Science PubMed FullText FullText_MUG

Steger, GG; Greil, R; Lang, A; Rudas, M; Fitzal, F; Mlineritsch, B; Hartmann, BL; Bartsch, R; Melbinger, E; Hubalek, M; Stoeger, H; Dubsky, P; Ressler, S; Petzer, AL; Singer, CF; Muss, C; Jakesz, R; Gampenrieder, SP; Zielinski, CC; Fesl, C; Gnant, M Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
ANN ONCOL. 2014; 25(2): 366-371. Doi: 10.1093/annonc/mdt508 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2008

Reitsamer, R; Sedlmayer, F; Kopp, M; Kametriser, G; Menzel, C; Glueck, S; Nairz, O; Deutschmann, H; Merz, F; Peintinger, F Concepts and techniques of intraoperative radiotherapy (IORT) for breast cancer.
Breast Cancer. 2008; 15(1): 40-46. Doi: 10.1007/s12282-007-0001-4
Web of Science PubMed FullText FullText_MUG

2007

Pötter, R; Gnant, M; Kwasny, W; Tausch, C; Handl-Zeller, L; Pakisch, B; Taucher, S; Hammer, J; Luschin-Ebengreuth, G; Schmid, M; Sedlmayer, F; Stierer, M; Reiner, G; Kapp, K; Hofbauer, F; Rottenfusser, A; Pöstlberger, S; Haider, K; Draxler, W; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
INT J RADIAT ONCOL BIOL PHYS. 2007; 68(2): 334-340. Doi: 10.1016/j.ijrobp.2006.12.045
Web of Science PubMed FullText FullText_MUG

2005

Jakesz, R; Jonat, W; Gnant, M; Mittlboeck, M; Greil, R; Tausch, C; Hilfrich, J; Kwasny, W; Menzel, C; Samonigg, H; Seifert, M; Gademann, G; Kaufmann, M Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
Lancet. 2005; 366(9484):455-462 Doi: 10.1016/S0140-6736(05)67059-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

1996

Chajés, V; Lhuillery, C; Sattler, W; Kostner, GM; Bougnoux, P Alpha-tocopherol and hydroperoxide content in breast adipose tissue from patients with breast tumors.
Int J Cancer. 1996; 67(2):170-175 Doi: 10.1002/(SICI)1097-0215(19960717)67:2<170::AID-IJC3>3.0.CO;2-Q
Web of Science PubMed FullText FullText_MUG

1986

Kopp, W; Fotter, R; Schneider, G Roentgen symptoms of early cancer of the breast
RADIOLOGE. 1986; 26: 498-502.
Web of Science PubMed

↑ Seitenanfang / Navigation

Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche